Evidence map›Paper›PMID 35982060›Full record

ArticleNature communications2022

Structural basis for cannabinoid-induced potentiation of alpha1-glycine receptors in lipid nanodiscs.

Arvind Kumar, Kayla Kindig, Shanlin Rao, Afroditi-Maria Zaki, Sandip Basak, Mark S P Sansom, Philip C Biggin, Sudha Chakrapani

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 22 citations in OpenAlex.

  1. Human GlyRα2 pore dynamics in gating and inhibition.Structure (London, England : 1993) · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Exploring the Activation Process of the Glycine Receptor.Journal of the American Chemical Society · 2024
    Article
  8. Pathology of pain and its implications for therapeutic interventions.Signal transduction and targeted therapy · 2024
    Review
  9. Article
  10. Antimicrobial, Probiotic, and Immunomodulatory Potential ofAntibiotics (Basel, Switzerland) · 2024
    Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Arvind KumarDepartment of Physiology and Biophysics, School of Medicine, Case Western Reserve University, Cleveland, OH, USA.ORCID 0000-0002-8421-8669
Kayla KindigDepartment of Physiology and Biophysics, School of Medicine, Case Western Reserve University, Cleveland, OH, USA.ORCID 0000-0001-8335-1436
Shanlin RaoDepartment of Biochemistry, University of Oxford, Oxford, UK.ORCID 0000-0003-4892-5523
Afroditi-Maria ZakiDepartment of Biochemistry, University of Oxford, Oxford, UK.ORCID 0000-0003-0992-9732
Sandip BasakDepartment of Physiology and Biophysics, School of Medicine, Case Western Reserve University, Cleveland, OH, USA.
Mark S P SansomDepartment of Biochemistry, University of Oxford, Oxford, UK.ORCID 0000-0001-6360-7959
Philip C BigginDepartment of Biochemistry, University of Oxford, Oxford, UK.ORCID 0000-0001-5100-8836
Sudha ChakrapaniDepartment of Physiology and Biophysics, School of Medicine, Case Western Reserve University, Cleveland, OH, USA. Sudha.chakrapani@case.edu.ORCID 0000-0003-0722-2338
Case Western Reserve University · USUniversity of Oxford · GB

Funding

Structure and Function of Pentameric Ligand-Gated Ion ChannelsR35GM134896 · NIGMS · CASE WESTERN RESERVE UNIVERSITY · PI Sudha Chakrapani · 2020 to 2026
$4.7M
MOLECULAR MECHANISMS OF DESENSITIZATION AND DRUG MODULATION IN LIGAND-GATED ION CHANNELSR01GM108921 · NIGMS · CASE WESTERN RESERVE UNIVERSITY · PI CHAKRAPANI, SUDHA · 2014 to 2018
$1.9M
STRUCTURE, FUNCTION, AND MODULATION OF SERORTONIN (3A) RECEPTORSR01GM131216 · NIGMS · CASE WESTERN RESERVE UNIVERSITY · PI CHAKRAPANI, SUDHA · 2019 to 2019
$442k
Biotechnology and Biological Sciences Research Council BB/N000145/1Biotechnology and Biological Sciences Research Council BB/S001247/1NIGMS NIH HHS R01 GM108921NIGMS NIH HHS R01 GM131216NIGMS NIH HHS R35 GM134896Wellcome TrustWellcome Trust 208361/Z/17/Z
6 · The paper itself

Abstract

Nociception and motor coordination are critically governed by glycine receptor (GlyR) function at inhibitory synapses. Consequentially, GlyRs are attractive targets in the management of chronic pain and in the treatment of several neurological disorders. High-resolution mechanistic details of GlyR function and its modulation are just emerging. While it has been known that cannabinoids such as Δ

Indexed as

CannabinoidsReceptors, GlycineDronabinolGlycineLipidsCannabinoidsDronabinolGlycineLipidsReceptors, Glycine

Identifiers

PMID35982060
PMCPMC9388682
OpenAlexW4292212985

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.